Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2558PDF: 734HTML: 2295 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2209PDF: 1037HTML: 1981Characteristic of study group: 196 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2079PDF: 1663HTML: 371 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2429PDF: 783HTML: 1735 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2911PDF: 880HTML: 1675 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1497PDF: 529HTML: 266 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2150PDF: 1465HTML: 262 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3872Suppl. Files: 1100PDF: 1061Html: 170 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2186PDF: 939HTML: 5057Cover Letter: 166Figure 2: 158Figure 1: 172Figure 3: 192Figure 4: 165Figure Legend: 181Table 1: 184Table 2: 177Table 3: 175 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3226PDF: 930HTML: 2948 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2816PDF: 845HTML: 6517Untitled: 223Untitled: 185Untitled: 199Untitled: 207 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7401PDF: 2412HTML: 1722Table 1.: 204Table 2.: 215Table 3.: 196Table 4.: 197 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3741PDF: 1645HTML: 11557Figures Haase: 194 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3564PDF: 876HTML: 6710 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1023PDF: 1147Suppl. Files: 569HTML: 81 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1174PDF: 748HTML: 1345Figure 1: 185Figure 2: 188 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1996PDF: 756HTML: 3112 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3854PDF: 1469HTML: 8509 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4271PDF: 1368HTML: 2035 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3537PDF: 1063HTML: 873 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1770PDF: 963HTML: 140 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3508PDF: 1549HTML: 78 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1307PDF: 805HTML: 125 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1792PDF: 799HTML: 10229Figures 1,2,3: 172 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1938PDF: 708HTML: 679Table1: patient's characteristics: 153Table 2: profile of each patient: 178







